Solubility and stability of melatonin in propylene glycol and 2-hydroxypropyl-β-cyclodextrin vehicles

Archives of Pharmacal Research

Volumn 20, Issue 6, 1997, Pages 560-565

  Lee, Beom Jin ^a   Choi, Han Gon ^b   Kim, Chong Kook ^b   Parrott, Keith A ^c   Ayres, James W ^c   Sack, Robert L ^d  

^a Kangwon National University   (South Korea)

^b Seoul National University   (South Korea)

^c OREGON STATE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

2 Hydroxypropyl cyclodextrin; Melatonin; Propylene glycol; Solubility; Stability

Indexed keywords

EID: 0008813163     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975212     Document Type: Article

References (21)

1. Barton, A. F. M., Handbook of Solubility Parameters and Other Cohesion Parameters. CRC Press, Inc. (1983).
2. Benes, L., Brun, J., Claustrat, B., Degrande, G., Dudoux, N., Geoffriau, M., Horriere, F.; Karsenty, H. and Lagain, D., Plasma melatonin (M) and Sulfatoxy-melatonin (aMT6s) kinetics after transmucosal administration to humans, In Touitou Y., Arendt J. and Pevet, P. (Eds). Melatonin and the Pineal Gland-from Basic Science to Clinical Application; Elsevier Science Publishers B.V., Amsterdam, Netherland, pp. 347-350, 1993.
3. Connors, K. A., Amidon, G. L. and Kennon, L., Chemical Stability of Pharmaceutical, A Handbook for Pharmacists. John Wiley & Sons, Inc., New York, 1979.
4. Dilbeck, G. A., Field, L., Gallo, A. A. and Gargiulo, R. J., Biologically oriented organic sulfur chemistry. 19. Synthesis and properties of 2-amino-5-mercapto-5-methylhexanoic acid, a bishomologue of penicillamine. Use of boron trifluoride etherate for catalyzing Markownikoff addition of a thiol to an olefin. J. Org. Chem., 43, 4593-4596 (1978).
5. Duchene, D. and Wouessidjewe, D., Physicochemical characteristics and pharmaceutical uses of cyclodextrin derivatives. Pharm. Tech., 14, 26-34 (1990).
6. Higuchi, T. and Connor, K., Phase solubility techniques. Adv. Anal. Chem. Instr., 4, 117-212 (1965).
7. Konsil, J., Parrott, K.A. and Ayres, J. W., Development of a transdermal delivery device for melatonin: in vitro study. Drug Dev. Ind. Pharm., 21, 1377-1387 (1995).
8. Lane, E. A. and Moss, H. B., Pharmacokinetics of melatonin in man:first pass hepatic metabolism. J. Clin. Endocrinol. Metab., 61, 1214-1216 (1985).
9. Lee, B.-J. and Min, G.-H., Oral controlled release of melatonin using polymer-reinforced and coated alginate beads. Int. J. Pharm., 144, 37-46 (1996).
10. Lee, B.-J. and Lee, J.-R., Enhancement of solubility and dissolution rate of poorly water-soluble naproxen by complexation with 2-hydroxypropy-β-cyclodextrin. Arch. Pharm. Res., 18, 22-26 (1995).
11. Lee, B.-J., Parrott, K. A., Ayres, J. W. and Sack, R. L., Design and evaluation of an oral controlled release delivery system for melatonin in human subjects. Int. J. Pharm., 124, 119-127 (1995).
12. Lee, B.-J., Parrott, K. A., Ayres, J. W. and Sack, R. L., Development and characterization of an oral controlled release delivery system for melatonin. Drug Dev. Ind. Pharm., 22, 269-274 (1996).
13. Lee, B.-J., Parrott, K. A., Ayres, J. W. and Sack, R. L., Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res. Comm. Mol. Pathol. Pharmacol., 85, 337-344 (1994).
14. Lerner, A. B., Case, J. D. and Heinzelman, R. V., Structure of melatonin. J. Am. Chem. Soc., 81, 6084-6085 (1959).
15. Loftsson, T., Bjornsdottir, S., Palsdottir, G. and Bodor, N., The effects of 2-hydroxypropyl-β-cyclodextrin on the solubility and stability of chlorambucil and melphalan in aqueous solution. Int. J. Pharm., 57, 63-72 (1989).
16. Marcus, A. D. and Taraszka, A. J., A kinetic study of the specific hydrogen ion catalyzed solvolysis of chloramphenicol in water-propylene glycol system. J. Pharm. Sci., 48, 77-84 (1959).
17. Muller, B. W. and Albers, E., Effects of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs. J. Pharm. Sci., 80, 599-604 (1991).
18. Waldhauser, F. and Dietzel, M., Daily and annual rhythms in human melatonin secretion: Role in puberty. Ann., N. Y. Acad Sci., 453, 205-214 (1985).
19. Waldahuser, F., Waldahuser, M., Lieberman, H. R., Deng, M., Lynch, H. J. and Wurtman, R. J., Bioavailability of oral melatonin in human. Neuroendocrinol., 39, 307-313 (1984).
20. Yalkowsky, S. H. and Rubino, J. T., Solubilization by cosolvents I: Organic solutes in propylene glycolwater mixtures. J. Pharm. Sci., 74, 416-421 (1985).
21. Yoshida, A., Arima, H., Uekama, K. and Pitha, J. Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrin. Int. J. Pharm., 46, 217-222 (1988).